Merriel SW, D, et al. Retrospective cohort study evaluating clinical, biochemical and Pharmacological prognostic factors for prostate cancer progression using primary care data. BMJ Open. 2021;11:e044420.

Article  PubMed  PubMed Central  Google Scholar 

Knight S, Shaw C, Pius R, GlobalSurg, Collaborative, National Institute for Health Research Global Health Research Unit on Global Surgery. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. Lancet. 2021;397:387–97.

Article  Google Scholar 

Liu B, et al. Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Therapy. 2024;9:175.

Article  Google Scholar 

Ratajczak MZ, et al. Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms. Leukemia. 2018;32:2519–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bustan H, Herz A. In vitro determination and differentiation of mouse teratocarcinoma toward myocardiogenesis. Dev Biol. 1977;59:1–11.

Article  CAS  PubMed  Google Scholar 

Chaudhary A, Raza SS, Haque R. Transcriptional factors targeting in cancer stem cells for tumor modulation. in YSCB. 2023. Elsevier.

Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275–84.

Article  CAS  PubMed  Google Scholar 

Krivtsov AV, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9. Nature. 2006;442:818–22.

Article  CAS  PubMed  Google Scholar 

Lin J-H, et al. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers Tamoxifen resistance on breast cancer cells. Breast Cancer Res Treat. 2018;172:45–59.

Article  CAS  PubMed  Google Scholar 

Yu K-D, et al. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. Breast Cancer Res Treat. 2010;121:485–96.

Article  CAS  PubMed  Google Scholar 

Razandi M, et al. Tamoxifen regulates cell fate through mitochondrial Estrogen receptor beta in breast cancer. Oncogene. 2013;32:3274–85.

Article  CAS  PubMed  Google Scholar 

Kocdogan AK, et al. Investigation of GST and drug resistance protein expressions in relation to chemotherapy in breast cancer. Health Probl Civiliz. 2025;19:148–62.

Article  Google Scholar 

Liu R et al. Identifying CTSF and GSTM3 as chemoresistance therapeutic targets in breast cancer through multi-omics MR analysis. iScience. 2025; 28:1–16.

Article  Google Scholar 

Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22:7369–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Depeille P, et al. Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol Pharmacol. 2004;65:897–905.

Article  CAS  PubMed  Google Scholar 

Talib WH, et al. Targeting drug chemo-resistance in cancer using natural products. Biomedicines. 2021;9:1353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seven D, Dalan AB, Bayrak ÖF. Targeting GSTM3 for therapeutic potential in advanced prostate cancer. BMC Cancer. 2025;25:1493.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh RR, Reindl KM. Glutathione S-transferases in cancer. Antioxidants. 2021;10:701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drozd E, et al. Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin. Biomed Pharmacother. 2016;83:397–406.

Article  CAS  PubMed  Google Scholar 

Zahmatkesh AK, Moqadami A, Khalaj-Kondori M. Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management. Iran J Basic Med Sci. 2023;26:1380.

Google Scholar 

Alden RS, et al. Glutamine metabolism and radiosensitivity: beyond the Warburg effect. Front Oncol. 2022;12:1070514.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McBrayer SK, et al. Transaminase Inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell. 2018;175:101–16. e25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rashmi R, et al. Glutaminase inhibitors induce thiol-mediated oxidative stress and radiosensitization in treatment-resistant cervical cancers. Mol Cancer Ther. 2020;19:2465–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei Z, et al. Metabolism of amino acids in cancer. Front Cell Dev Biology. 2021;8:603837.

Article  Google Scholar 

Zahmatkesh AK, et al. GLUL gene knockdown and restricted glucose level show synergistic inhibitory effect on the luminal subtype breast cancer MCF7 cells’ proliferation and metastasis. EXCLI J. 2023;22:847.

Google Scholar 

Fu S, et al. Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair. Cell Rep. 2019;28:1136–43. e4.

Article  CAS  PubMed  Google Scholar 

Peng Y, et al. Glutamine synthetase facilitates cancer cells to recover from irradiation-induced G2/M arrest. Cancer Biol Ther. 2020;21:43–51.

Article  CAS  PubMed  Google Scholar 

Vardhana SA, et al. Glutamine independence is a selectable feature of pluripotent stem cells. Nat Metabolism. 2019;1:676–87.

Article  CAS  Google Scholar 

Ma J, et al. Emerging roles for fatty acid oxidation in cancer. Genes Dis. 2025;12:101491.

Article  CAS  PubMed  Google Scholar 

Schafer ZT, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461:109–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carracedo A, et al. A metabolic prosurvival role for PML in breast cancer. J Clin Investig. 2012;122:3088–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

Article  CAS  PubMed  Google Scholar 

Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149:1177–90. e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci. 2018;6:31.

Google Scholar 

Khalek FJA, Gallicano GI, Mishra L. Colon cancer stem cells. Gastrointest Cancer Research: GCR. 2010; Nov-Dec;(Suppl 1):S16–S.

Ben-Porath I, et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507.

Article  CAS